Differential activation of human γδ cells by nonpeptide phosphoantigens

European Journal of Immunology

Volumn 31, Issue 5, 2001, Pages 1628-1635

  Sireci, Guido ^a   Espinosa, Eric ^b   Di Sano, Caterina ^a   Dieli, Francesco ^a   Fournié, Jean Jacques ^b   Salerno, Alfredo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CHU PURPAN   (France)

Author keywords

TCR; Activation; Agonist; Antagonist; Down regulation; Lymphocyte

Indexed keywords

3 FORMYL 1 BUTYLPYROPHOSPHATE; ANTIGEN; BETA DEXTRO RIBOSYL 1 PHOSPHATE; BROMOHYDRIN PYROPHOSPHATE; ISOPENTENYL DIPHOSPHATE; LIGAND; PEPTIDE; PHOSPHATE; PYROPHOSPHORIC ACID DERIVATIVE; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISSOCIATION; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; METABOLIC ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SENSOR; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TIME;

ACIDS; ANTIGENS; CELLS, CULTURED; CLONE CELLS; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; LYMPHOCYTE ACTIVATION; MOLECULAR STRUCTURE; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035017686     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T     Document Type: Article

References (49)

1. Lanzavecchia, A., Lezzi, G. and Viola, A., From TCR engagement to T cell activation: a kinetic view of T cell behaviour. Cell 1999. 96: 1-4.
2. Rabinowitz, J. D., Beeson, C., Wulfing, C., Tate, K., Allen, P. M., Davis, M. M. and McConnell, H. M., Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 1996. 5: 125-135.
3. Weiss, A. and Littman, D. R., Signal transduction by lymphocyte antigen receptors. Cell 1994. 76: 263-274.
4. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 1996. 14: 1-27
5. Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B. and Chien, Y., Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 1998. 16: 523-544.
6. Holoshitz, J., Romzek, N. C., Jia, Y., Wagner, L., Vila, L. M., Chen, S. J., Wilson, J. M. and Karp, D. R., MHC-independent presentation of mycobacteria to human gamma delta T cells. Int. Immunol. 1993. 5: 1437-1443.
7. Lang, F., Peyrat, M. A., Constant, P., Davodeau, F., David-Ameline, J., Poquet, Y., Vie, H., Fournie, J. J. and Bonneville, M., Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 1995. 154: 5986-5994.
8. Monta, C. T., Beckman, E. M., Bukowski, J. F., Tanaka, Y., Band, H., Bloom, B. R., Golan, D. E. and Brenner, M. B., Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995. 3: 495-507.
9. Davodeau, F., Peyrat, M. A., Hallet, M. M., Gaschet, J., Houde, I., Vivien, R., Vie, H. and Bonneville, M., Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. J. Immunol. 1993. 151: 1214-1223.
10. Bukowski, J. F., Morita, C. T., Tanaka, Y., Bloom, B. R., Brenner, M. B. and Band, H., V gamma 2 V delta 2 TCR-dependent recognition of nonpeptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 1995. 154: 998-1006.
11. Bukowski, J. F., Morita, C. T., Band, H. and Brenner, M. B., Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma-delta T cells. J. Immunol. 1998. 161: 286-293.
12. Constant, P., Davodeau, F., Peyrat, M. A., Poquet, Y., Puzo, G., Bonneville, M. and Fourniè, J. J., Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 1994. 264: 267-270.
13. Tanaka, Y., Morita, C. T., Nieves, E., Brenner, M. B. and Bloom, B. R., Natural and synthethic non-peptide antigens recognized by human gamma delta T cells. Nature 1995. 3757: 155-158.
14. Belmant, C., Espinosa, E., Poupot, R., Peyrat, M. A., Guiraud, M., Poquet, Y., M., B. and Fournié, J. J., 3-Formyl-1-butyl pyrophosphate. A novel mycobacterial metabolite-activating human gamma delta T cells. J. Biol. Chem. 1999. 274: 32079-32084.
15. Fournié, J. J. and Bonneville, M., Stimulation of gamma delta T cells by phosphoantigens. Res. Immunol. 1996. 147: 338-347.
16. Bukowski, J. F., Morita, C. T. and Brenner, M. B., Human gamma delta T cells recognize alkylamines derived from microbes, edible plants and tea: implications for innate immunity. Immunity 1999. 11: 57-65.
17. Burk, M. R., Mori, L. and De Libero, G., Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 1995. 25: 2052-2058.
18. Burk, M. R., Carena, I., Donda, A., Mariani, F., Mori, L. and De Libero, G., Functional inactivation in the whole population of human V gamma 8/V delta 2 T lymphocytes induced by a non-peptidic antagonist. J. Exp. Med. 1997. 185: 91-97.
19. Tanaka, Y., Sano, S., Nieves, E., De Libero, G., Rosa, D., Modlin, R. L., Brenner, M. B., Bloom, B. R. and Morita, C. T., Non-peptide ligands for human gamma delta T cells. Proc. Natl. Acad. Sci. USA 1994. 91: 8175-8179.
20. Kunzmann, V., Bauer, E. and Wilhelm, M., γδ T cell stimulation by pamidronate. N. Engl. J. Med. 1999. 340: 737.
21. Belmant, C., Espinosa, E., Halary, F., Tang, Y., Peyrat, M. A., Sicard, H., Kozikowski, A., Buelow, R., Poupot, R., Bonneville, M. and Fournié, J. J., A chemical basis for selective recognition of nonpeptide antigens by human gamma delta T cells. FASEB J. 2000. 14:1669-1670.
22. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A., Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 1996. 183: 1917-1921.
23. + T cells. J. Exp. Med. 1997. 186: 757-766.
24. McConnell, H. M., Owicki, J. C., Parce, J. W., Miller, D. L., Baxter, G. T., Wada, H. G. and Pitchford, S., The cytosensor microphysiometer: biological applications of silicon technology. Science 1992. 257: 1906-1912.
25. Beeson, C., Rabinowitz, J., Tate, K., Gutgemann, I., Chien, Y. H., Jones, P. P., Davis, M. M. and McConnell, H. M., Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J. Exp. Med. 1996. 184: 777-782.
26. Wulfing, C., Rabinowitz, J. D., Beeson, C., Sjaastad, M. D., McConnell, H. M. and Davis, M. M., Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 1997. 2057 185: 1815-1825.
27. Schmitt, L., Boniface, J. J., Davis, M. M. and McConnell, H. M., Kinetic isomers of a class II MHC-peptide complexes. Biochemistry 1998. 37: 17371-17380.
28. Boniface, J. J., Rabinowitz, J. D., Wulfing, C., Hampl, J., Reich, Z., Altman, J. D., Kantor, R. M., Beeson, C., McConnell, H. M. and Davis, M. M., Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 1998. 9: 459-466.
29. Schmitt, L., Boniface, J. J., Davis, M. M. and McConnell, H. M., Conformational isomers of a class II MHC-peptide complex in solution. J. Mol. Biol. 1999. 286: 207-218.
30. Ferrarini, M., Heltai, S., Toninelli, E., Sabbadini, M. G., Pellicciari, C. and Manfredi, A. A., Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes. J. Immunol. 1995. 154: 3704-3712.
31. Valitutti, S., Muller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
32. + T cells. J. Exp. Med. 1997. 185: 641-651.
33. Itoh, Y., Hemmer, B., Martin, R. and Germain, R. N., Serial TCR engagement by peptide: MHC molecule ligands: relationships to the quality of individual TCR signaling events. J. Immunol. 1999. 7 162: 2073-2080.
34. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable tresholds. Science 1996. 273: 104-106.
35. Lauritsen, J. P., Christensen, M. D., Dietrich, J., Kastrup, J., Odum, N. and Geisler, C., Two distinct pathways exist for down-regulation of the TCR. J. Immunol. 1998. 161: 260-267.
36. Dietrich, J., Hou, X., Wegener, A. M. and Geisler, C., CD3gamma contains a phosphoserine-dependent di-leucine-based motif involved in down-regulation of the T cell receptor. EMBO J. 1994. 13: 2156-2166.
37. Dietrich, J., Hou, X., Wegener, A. M., Pedersen, L. O., Odum, N. and Geisler, C., Molecular characterization of the di-leucine-based internalization motif of the T cell receptor.J. Biol. Chem. 1996. 271: 11441-11448.
38. Dietrich, J., Kastrup, J., Nielsen, B. L., Odum, N. and Geisler, C., Regulation and function of the CD3gamma DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. J. Cell. Biol. 1997. 138: 271-281.
39. Dietrich, J., Backstrom, T., Lauritsen, J. P. H., Kastrup, J., Christensen, M. D., von Bulow, F., Palmer, E. and Geisler, C., The phosphorylation state of CD3 gamma influences T cell responsiveness and controls T cell receptor cycling. J. Biol. Chem. 1998. 273: 24232-24238.
40. Bronstein-Sitton, N., Wang, L., Cohen, L. and Baniyash, M., Expression of the T cell antigen receptor zeta chain following activation is controlled at different checkpoints. Implications for cell surface receptor down-modulation and reexpression. J. Biol. Chem. 1999. 274: 23659-23665.
41. Niedergang, F., San Jose, E., Rubin, B., Alarcon, B., Dautry-Varsat, A. and Alcover, A., Differential cytosolic tail dependence and intracellular fate of T cell receptors internalized upon activation with superantigen or phorbol ester. Res. Immunol. 1997. 148: 231-245.
42. Niedergang, F., Dautry-Varsat, A. and Alcover, A., Peptide antigen or superantigen-induced down-regulation of TCRs involves both stimulated and unstimulated receptors. J. Immunol. 1997. 159: 1703-1710.
43. Rothenberg, E. V., How T cells count. Science 1996. 273: 78-79.
44. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A., Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur. J. Immunol. 1996. 26: 2012-2016.
45. Valitutti, S., Muller, S., Salio, M. and Lanzavecchia, A., Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J. Exp. Med. 1997. 185: 1859-1864.
46. Viola, A., Linkert, S. and Lanzavecchia, A., A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies. Eur. J. Immunol. 1997. 27: 3080-3083.
47. La Face, D. M., Couture, C., Anderson, K., Shin, G., Alexander, J., Sette, A., Mustelin, T., Altman, A. and Grey, H. M., Differential T cell signaling induced by antagonist peptide-MHC complexes. J. Immunol. 1997. 158: 2057-2064.
48. + T cells transfectants as antigen presenting cells. Immunol. Rev. 1998. 165: 249-265.
49. Dieli, F., Troye-Blomberg, M., Ivanyi, J., Fournie, J. J., Bonneville, M., Peyrat, M. A., Sireci, G. and Salerno, A., Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 2000. 30: 1512-1519.